Clinical Trial Update: Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant palliative capecitabine and gemcitabine in locally advanced or metastatic biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer
• Liver Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED